Copyright Reports & Markets. All rights reserved.

Global Prophylactic Gamma Globulin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Prophylactic Gamma Globulin Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 IVIg Liquid
    • 1.3.3 IVIg Powder
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Prophylactic Gamma Globulin Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Immunodeficiency
    • 1.4.3 Autoimmune Disease
    • 1.4.4 Acute Infection
  • 1.5 Global Prophylactic Gamma Globulin Market Size & Forecast
    • 1.5.1 Global Prophylactic Gamma Globulin Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Prophylactic Gamma Globulin Sales Quantity (2021-2032)
    • 1.5.3 Global Prophylactic Gamma Globulin Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Baxter
    • 2.1.1 Baxter Details
    • 2.1.2 Baxter Major Business
    • 2.1.3 Baxter Prophylactic Gamma Globulin Product and Services
    • 2.1.4 Baxter Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Baxter Recent Developments/Updates
  • 2.2 Grifols
    • 2.2.1 Grifols Details
    • 2.2.2 Grifols Major Business
    • 2.2.3 Grifols Prophylactic Gamma Globulin Product and Services
    • 2.2.4 Grifols Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Grifols Recent Developments/Updates
  • 2.3 Octapharma
    • 2.3.1 Octapharma Details
    • 2.3.2 Octapharma Major Business
    • 2.3.3 Octapharma Prophylactic Gamma Globulin Product and Services
    • 2.3.4 Octapharma Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Octapharma Recent Developments/Updates
  • 2.4 Biotest
    • 2.4.1 Biotest Details
    • 2.4.2 Biotest Major Business
    • 2.4.3 Biotest Prophylactic Gamma Globulin Product and Services
    • 2.4.4 Biotest Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Biotest Recent Developments/Updates
  • 2.5 Kedrion Biopharma
    • 2.5.1 Kedrion Biopharma Details
    • 2.5.2 Kedrion Biopharma Major Business
    • 2.5.3 Kedrion Biopharma Prophylactic Gamma Globulin Product and Services
    • 2.5.4 Kedrion Biopharma Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Kedrion Biopharma Recent Developments/Updates
  • 2.6 Takeda
    • 2.6.1 Takeda Details
    • 2.6.2 Takeda Major Business
    • 2.6.3 Takeda Prophylactic Gamma Globulin Product and Services
    • 2.6.4 Takeda Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Takeda Recent Developments/Updates
  • 2.7 ADMA Biologics
    • 2.7.1 ADMA Biologics Details
    • 2.7.2 ADMA Biologics Major Business
    • 2.7.3 ADMA Biologics Prophylactic Gamma Globulin Product and Services
    • 2.7.4 ADMA Biologics Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 ADMA Biologics Recent Developments/Updates
  • 2.8 BPL
    • 2.8.1 BPL Details
    • 2.8.2 BPL Major Business
    • 2.8.3 BPL Prophylactic Gamma Globulin Product and Services
    • 2.8.4 BPL Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 BPL Recent Developments/Updates
  • 2.9 LFB Group
    • 2.9.1 LFB Group Details
    • 2.9.2 LFB Group Major Business
    • 2.9.3 LFB Group Prophylactic Gamma Globulin Product and Services
    • 2.9.4 LFB Group Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 LFB Group Recent Developments/Updates
  • 2.10 Hualan Biological
    • 2.10.1 Hualan Biological Details
    • 2.10.2 Hualan Biological Major Business
    • 2.10.3 Hualan Biological Prophylactic Gamma Globulin Product and Services
    • 2.10.4 Hualan Biological Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Hualan Biological Recent Developments/Updates
  • 2.11 Beijing Tiantan Biological
    • 2.11.1 Beijing Tiantan Biological Details
    • 2.11.2 Beijing Tiantan Biological Major Business
    • 2.11.3 Beijing Tiantan Biological Prophylactic Gamma Globulin Product and Services
    • 2.11.4 Beijing Tiantan Biological Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Beijing Tiantan Biological Recent Developments/Updates
  • 2.12 Beijing Bohui Innovation Biotechnology
    • 2.12.1 Beijing Bohui Innovation Biotechnology Details
    • 2.12.2 Beijing Bohui Innovation Biotechnology Major Business
    • 2.12.3 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Product and Services
    • 2.12.4 Beijing Bohui Innovation Biotechnology Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Beijing Bohui Innovation Biotechnology Recent Developments/Updates
  • 2.13 Pacific Shuanglin Bio-pharmacy
    • 2.13.1 Pacific Shuanglin Bio-pharmacy Details
    • 2.13.2 Pacific Shuanglin Bio-pharmacy Major Business
    • 2.13.3 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Product and Services
    • 2.13.4 Pacific Shuanglin Bio-pharmacy Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Pacific Shuanglin Bio-pharmacy Recent Developments/Updates
  • 2.14 Shenzhen Weiguang Biological
    • 2.14.1 Shenzhen Weiguang Biological Details
    • 2.14.2 Shenzhen Weiguang Biological Major Business
    • 2.14.3 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Product and Services
    • 2.14.4 Shenzhen Weiguang Biological Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Shenzhen Weiguang Biological Recent Developments/Updates
  • 2.15 CBPO
    • 2.15.1 CBPO Details
    • 2.15.2 CBPO Major Business
    • 2.15.3 CBPO Prophylactic Gamma Globulin Product and Services
    • 2.15.4 CBPO Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 CBPO Recent Developments/Updates
  • 2.16 CNBG
    • 2.16.1 CNBG Details
    • 2.16.2 CNBG Major Business
    • 2.16.3 CNBG Prophylactic Gamma Globulin Product and Services
    • 2.16.4 CNBG Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 CNBG Recent Developments/Updates
  • 2.17 Shanghai RAAS
    • 2.17.1 Shanghai RAAS Details
    • 2.17.2 Shanghai RAAS Major Business
    • 2.17.3 Shanghai RAAS Prophylactic Gamma Globulin Product and Services
    • 2.17.4 Shanghai RAAS Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Shanghai RAAS Recent Developments/Updates
  • 2.18 Sichuan Yuanda Shuyang
    • 2.18.1 Sichuan Yuanda Shuyang Details
    • 2.18.2 Sichuan Yuanda Shuyang Major Business
    • 2.18.3 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Product and Services
    • 2.18.4 Sichuan Yuanda Shuyang Prophylactic Gamma Globulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Sichuan Yuanda Shuyang Recent Developments/Updates

3 Competitive Environment: Prophylactic Gamma Globulin by Manufacturer

  • 3.1 Global Prophylactic Gamma Globulin Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Prophylactic Gamma Globulin Revenue by Manufacturer (2021-2026)
  • 3.3 Global Prophylactic Gamma Globulin Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Prophylactic Gamma Globulin by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Prophylactic Gamma Globulin Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Prophylactic Gamma Globulin Manufacturer Market Share in 2025
  • 3.5 Prophylactic Gamma Globulin Market: Overall Company Footprint Analysis
    • 3.5.1 Prophylactic Gamma Globulin Market: Region Footprint
    • 3.5.2 Prophylactic Gamma Globulin Market: Company Product Type Footprint
    • 3.5.3 Prophylactic Gamma Globulin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Prophylactic Gamma Globulin Market Size by Region
    • 4.1.1 Global Prophylactic Gamma Globulin Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Prophylactic Gamma Globulin Consumption Value by Region (2021-2032)
    • 4.1.3 Global Prophylactic Gamma Globulin Average Price by Region (2021-2032)
  • 4.2 North America Prophylactic Gamma Globulin Consumption Value (2021-2032)
  • 4.3 Europe Prophylactic Gamma Globulin Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Prophylactic Gamma Globulin Consumption Value (2021-2032)
  • 4.5 South America Prophylactic Gamma Globulin Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Prophylactic Gamma Globulin Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Prophylactic Gamma Globulin Sales Quantity by Type (2021-2032)
  • 5.2 Global Prophylactic Gamma Globulin Consumption Value by Type (2021-2032)
  • 5.3 Global Prophylactic Gamma Globulin Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Prophylactic Gamma Globulin Sales Quantity by Application (2021-2032)
  • 6.2 Global Prophylactic Gamma Globulin Consumption Value by Application (2021-2032)
  • 6.3 Global Prophylactic Gamma Globulin Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Prophylactic Gamma Globulin Sales Quantity by Type (2021-2032)
  • 7.2 North America Prophylactic Gamma Globulin Sales Quantity by Application (2021-2032)
  • 7.3 North America Prophylactic Gamma Globulin Market Size by Country
    • 7.3.1 North America Prophylactic Gamma Globulin Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Prophylactic Gamma Globulin Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Prophylactic Gamma Globulin Sales Quantity by Type (2021-2032)
  • 8.2 Europe Prophylactic Gamma Globulin Sales Quantity by Application (2021-2032)
  • 8.3 Europe Prophylactic Gamma Globulin Market Size by Country
    • 8.3.1 Europe Prophylactic Gamma Globulin Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Prophylactic Gamma Globulin Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Prophylactic Gamma Globulin Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Prophylactic Gamma Globulin Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Prophylactic Gamma Globulin Market Size by Region
    • 9.3.1 Asia-Pacific Prophylactic Gamma Globulin Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Prophylactic Gamma Globulin Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Prophylactic Gamma Globulin Sales Quantity by Type (2021-2032)
  • 10.2 South America Prophylactic Gamma Globulin Sales Quantity by Application (2021-2032)
  • 10.3 South America Prophylactic Gamma Globulin Market Size by Country
    • 10.3.1 South America Prophylactic Gamma Globulin Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Prophylactic Gamma Globulin Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Prophylactic Gamma Globulin Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Prophylactic Gamma Globulin Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Prophylactic Gamma Globulin Market Size by Country
    • 11.3.1 Middle East & Africa Prophylactic Gamma Globulin Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Prophylactic Gamma Globulin Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Prophylactic Gamma Globulin Market Drivers
  • 12.2 Prophylactic Gamma Globulin Market Restraints
  • 12.3 Prophylactic Gamma Globulin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Prophylactic Gamma Globulin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Prophylactic Gamma Globulin
  • 13.3 Prophylactic Gamma Globulin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Prophylactic Gamma Globulin Typical Distributors
  • 14.3 Prophylactic Gamma Globulin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Prophylactic Gamma Globulin market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    The gamma globulin fraction of pooled normal human sera has a wide range of usefulness in the prophylaxis of many infectious diseases. Hyperimmune human globulin preparations are effective against certain other illnesses in which globulins pooled from normal sera contain insufficient antibody.
    This report is a detailed and comprehensive analysis for global Prophylactic Gamma Globulin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Prophylactic Gamma Globulin market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Prophylactic Gamma Globulin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Prophylactic Gamma Globulin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Prophylactic Gamma Globulin market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Prophylactic Gamma Globulin
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Prophylactic Gamma Globulin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, Grifols, Octapharma, Biotest, Kedrion Biopharma, Takeda, ADMA Biologics, BPL, LFB Group, Hualan Biological, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Prophylactic Gamma Globulin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    IVIg Liquid
    IVIg Powder
    Market segment by Application
    Immunodeficiency
    Autoimmune Disease
    Acute Infection
    Major players covered
    Baxter
    Grifols
    Octapharma
    Biotest
    Kedrion Biopharma
    Takeda
    ADMA Biologics
    BPL
    LFB Group
    Hualan Biological
    Beijing Tiantan Biological
    Beijing Bohui Innovation Biotechnology
    Pacific Shuanglin Bio-pharmacy
    Shenzhen Weiguang Biological
    CBPO
    CNBG
    Shanghai RAAS
    Sichuan Yuanda Shuyang
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Prophylactic Gamma Globulin product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Prophylactic Gamma Globulin, with price, sales quantity, revenue, and global market share of Prophylactic Gamma Globulin from 2021 to 2026.
    Chapter 3, the Prophylactic Gamma Globulin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Prophylactic Gamma Globulin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Prophylactic Gamma Globulin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Prophylactic Gamma Globulin.
    Chapter 14 and 15, to describe Prophylactic Gamma Globulin sales channel, distributors, customers, research findings and conclusion.

    Buy now